Our Philosophy

Company Philosophy

One and only objective of a Corporate Philosophy for Britannia Biological LLP is to deliver quality products at affordable rate.

We are engage in developing low cost medicines by engaging R&D for production optimization, increasing our product range and adding more lines to our production facilities and are focused to build a production empire so we may pursue our goal of achieving what we propagate.

Mission

To continue to be recognised as a reliable provider of healthcare products and services by customers the world over.
To provide superior value to our customers and stakeholders, by being innovative, focused and specialized.
To create and sustain a work environment that values people, promotes learning, nurtures innovation and leads to collective excellence.

Vision

To attain leadership in all our business units
To be respected and admired by patients, physicians and all stake-holders in our business
To achieve sustained sales and profit growth

Pharmacy industry woman worker in protective clothing operating production of tablets in sterile working conditions

Credo

Customer Orientation

To recognize that the customer is most important for our survival and growth
To interact with customers with regularity and treat each customer as the only and most important one
To create and sustain long-term relationships with customers
To receive customer’s feedback and give it your highest attention

Commitment

To human dignity – respect for all, respect differences in culture, language, opinions
To integrity – demonstrate consistency in actions and words
To business goals – making it happen consistently

Our Strengths

Research: The Company’s strength in research and people has been the cornerstone of its success.
Culture: The Company is opportunity-driven, responding to new ideas and developments with industrial discipline on the one hand and strategic flexibility on the other.
Integration: The Company is integrated across the value chain – APIs to formulations – in the manufacture of select products leading to corresponding advantages in terms of cost, quality and logistics.
Spread: The Company addresses opportunities across the oncology, CNS, gastrointestinal, migraine and anti-depressant segments, each of which is growing in size and scope.
Intellectual Capital: The company demonstrated a high retention of senior management professionals over the last number of years, catalyzing relationships management across all stakeholders and informed decision-making.
Research Effectiveness: Research Effectiveness: A majority of the company’s oncology basket of products were first generic versions in India.
Innovation: The company leveraged its deep understand of manufacturing equipment to make design improvements that helped moderate capital expenditure and enhance profitability.